Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Japan”

A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab StudyActive Not Recruiting
NCT03768063Phase 3Updated Jul 24, 2026
Sponsor: Hoffmann-La Roche
Cancer
United States, Australia, Belgium, Brazil, Bulgaria +19 more
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung CancerRecruiting
NCT06712355Phase 3Updated Jul 24, 2026
Sponsor: BioNTech SE
Extensive-stage Small-cell Lung Cancer
United States, Australia, China, France, Germany +9 more
A Phase III Trial of Z-338 in Paediatric Patients With Functional DyspepsiaCompleted
NCT04526119Phase 3Updated Jul 24, 2026
Sponsor: Zeria Pharmaceutical
Functional Dyspepsia
Japan
Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate CancerActive Not Recruiting
NCT03456843Phase 2Updated Jul 24, 2026
Sponsor: Yale University
Stage IV Prostate Adenocarcinoma AJCC v7
United States, Australia, China, Japan, South Korea +1 more
Intra-operative Pancreatoscopy in Patients With IPMNActive Not Recruiting
NCT03729453N/AUpdated Jul 24, 2026
Sponsor: Boston Scientific Corporation
Intraductal Papillary Mucinous Neoplasm
United States, China, India, Japan, Netherlands +1 more
A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Japanese Healthy People and Japanese People With Obesity or OverweightRecruiting
NCT07693231Phase 1Updated Jul 24, 2026
Sponsor: Boehringer Ingelheim
Healthy · Obesity
Japan
A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.Completed
NCT05523167Phase 2, Phase 3Updated Jul 24, 2026
Sponsor: argenx
Active Idiopathic Inflammatory Myopathy · Myositis · Dermatomyositis · Polymyositis
United States, Argentina, Australia, Austria, Belgium +31 more
Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.Active Not Recruiting
NCT05201066Phase 2Updated Jul 24, 2026
Sponsor: Novartis Pharmaceuticals
Myelodysplastic Syndromes · Leukemia, Myelomonocytic, Chronic
United States, Australia, Brazil, Canada, China +10 more
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)Recruiting
NCT06929273Phase 3Updated Jul 24, 2026
Sponsor: Bristol-Myers Squibb
Bipolar Disorder Type I With Mania
United States, Argentina, Australia, Bulgaria, China +15 more
Phase 1, First in Human (FIH), Open-Label, Single-Arm, Ascending Dose Study to Assess the Safety, Tolerability and Preliminary Immunogenicity of ITI-9001 in Japanese Patients With Japanese Red Cedar (JRC) PollinosisRecruiting
NCT07726147Phase 1Updated Jul 24, 2026
Sponsor: Immunomic Therapeutics, Inc.
Allergen Immunotherapy
Japan
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesityRecruiting
NCT07037433Phase 3Updated Jul 24, 2026
Sponsor: Amgen
Atherosclerotic Cardiovascular Disease · Overweight · Obesity
United States, Argentina, Australia, Austria, Belgium +31 more
A Study to Evaluate How the Study Drug Moves Through the Body, Adverse Events, and How the Body Tolerates ABBV-547 InjectionsActive Not Recruiting
NCT07232004Phase 1Updated Jul 24, 2026
Sponsor: AbbVie
Healthy Volunteer
United States, Japan
Additional Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord InjuryNot Yet Recruiting
NCT07722962Phase 3Updated Jul 23, 2026
Sponsor: Kringle Pharma, Inc.
Acute Spinal Cord Injury (SCI)
Japan
A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)Completed
NCT05398445Phase 3Updated Jul 23, 2026
Sponsor: Amgen
Atopic Dermatitis
United States, Argentina, Brazil, Canada, China +16 more
Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)Active Not Recruiting
NCT05925803Phase 3Updated Jul 23, 2026
Sponsor: AstraZeneca
Systemic Sclerosis · Scleroderma
United States, Austria, Belgium, Canada, China +18 more
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsRecruiting
NCT05836324Phase 1Updated Jul 23, 2026
Sponsor: Incyte Corporation
Solid Tumors · Advanced Solid Tumors · Metastatic Solid Tumors
United States, China, Denmark, France, Italy +4 more
A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C MutationRecruiting
NCT07172919Phase 2Updated Jul 23, 2026
Sponsor: Amgen
Advanced Solid Tumors
United States, Australia, France, Germany, Greece +4 more
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung CancerActive Not Recruiting
NCT06012435Phase 3Updated Jul 23, 2026
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Carcinoma, Non-Small-Cell Lung
United States, Argentina, Australia, Austria, Belgium +20 more
Characterization And Clinical Outcomes of AA Patients Treated With RitlecitinibRecruiting
NCT06531109N/AUpdated Jul 23, 2026
Sponsor: Pfizer
Alopecia Areata
United States, China, France, Italy, Japan +1 more
Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV)Completed
NCT04058990NAUpdated Jul 23, 2026
Sponsor: Boston Scientific Corporation
Coronary Artery Disease
Japan
cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-AsiaRecruiting
NCT06686485N/AUpdated Jul 23, 2026
Sponsor: Boston Scientific Corporation
Concomitant Procedures · Atrial Fibrillation · PFA · LAAC
China, Hong Kong, Japan, Malaysia, Singapore +1 more
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)Recruiting
NCT07202546Phase 2Updated Jul 23, 2026
Sponsor: ViiV Healthcare
HIV Infections
United States, Argentina, Australia, Belgium, Canada +9 more
A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast CancerActive Not Recruiting
NCT03975647Phase 3Updated Jul 23, 2026
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
HER2-positive Breast Cancer
United States, Australia, Austria, Belgium, Canada +15 more
A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent ChemoradiotherapyActive Not Recruiting
NCT04543617Phase 3Updated Jul 23, 2026
Sponsor: Hoffmann-La Roche
Esophageal Squamous Cell Carcinoma
United States, Argentina, Australia, Austria, Belgium +23 more
Selatogrel Outcome Study in Suspected Acute Myocardial InfarctionEnrolling By Invitation
NCT04957719Phase 3Updated Jul 23, 2026
Sponsor: Viatris Innovation GmbH
Acute Myocardial Infarction
United States, Australia, Austria, Belgium, Brazil +40 more

Previous page Next page